I was living a normal 29-year-old life. I thought my symptoms were no big deal, until they started happening more ...

For years, researchers have noted an alarming rise in colorectal cancer in younger people that’s not fully explained away by ...

Saga Diagnostics expanded the use of its ultrasensitive blood test to include detection of tiny amounts of colorectal cancer ...

Regular walking during recovery may reduce cancer-related fatigue and improve long-term well-being for patients with ...

Just 10 minutes of intense exercise triggered surprising changes in colon cancer cells in a new study. Here’s what that may ...

GLP-1 drugs are 36% more effective than aspirin in reducing colorectal cancer risk, with fewer side effects like acute kidney ...

Ozempic and Wegovy might help people avoid colon cancer as well as promote weight loss or control diabetes, a new study says.

Benefits of GLP-1 RAs were consistent across age groups and BMI categories, with semaglutide showing significant efficacy. These results were presented during the press briefing ahead of the 2026 ...

The use of GLP-1 receptor antagonist therapy has led to a greater reduction in colorectal cancer incidence than has been observed with aspirin.

GLP-1 receptor agonists may be superior to aspirin for primary prevention of colorectal cancer, according to study results ...

Panelists discuss how available third-line therapies, such as FTD/TPI, regorafenib, and others, are chosen based on survival data, safety, and patient quality of life. Panelists discuss how the ...